2020 Biology of Acute Respiratory Infection Gordon Research Conference and Gordon Research Seminar
2020急性呼吸道感染生物学戈登研究大会暨戈登研究研讨会
基本信息
- 批准号:9913675
- 负责人:
- 金额:$ 0.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-05 至 2021-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Abstract
Respiratory infections are a leading cause of morbidity and mortality worldwide. The measles outbreak and
continued increase of antibiotic resistant bacterial infections are stark reminders of the urgent public health
risks of these infections. The purpose of this proposal is to provide funds to support travel support for invited
speakers and young scientists to present and attend the 2020 Gordon Research Conference (GRC) Biology
of Acute Respiratory Infection, which will be held in Galveston, Texas February 16-21, 2020. This
conference will bring together groups of scientists, from basic to applied, public health officials and clinicians
that normally do not attend the same meetings to highlight new findings and concepts in respiratory tract
infections including, disease in vulnerable populations, intrinsic, innate and adaptive immune responses,
infection-mediated exacerbations in individuals with lung diseases, the future for respiratory vaccines and
exciting new models and tools. It will be especially important to encourage a new generation of young
scientists to not only study respiratory infections, but to build networks allowing them to take a “wholistic”
approach to research. Although there are a few meetings dedicated to specific respiratory microbes or
systems, this is the only meeting focused on bringing a diverse community together and encouraging young
investigator participation making it unique.
抽象的
呼吸道感染是全球发病率和死亡率的主要原因。麻疹爆发和
抗生素耐药细菌感染的持续增加是对Urget公共卫生的鲜明提醒
这些感染的风险。该提案的目的是提供资金,以支持受邀旅行支持
演讲者和年轻科学家介绍和参加2020年戈登研究会议(GRC)生物学
急性呼吸感染,该感染将于2020年2月16日至21日在德克萨斯州加尔维斯顿举行。
会议将汇集一群科学家,从基本到应用,公共卫生官员和临床医生
通常,这不会参加相同的会议,以突出呼吸道中的新发现和概念
感染,包括弱势群体,内在,先天和适应性免疫复杂的疾病,
感染介导的肺部疾病患者的加重,呼吸疫苗的未来和
令人兴奋的新模型和工具。鼓励新一代的年轻人尤其重要
科学家不仅要研究呼吸道感染,而且要建立网络,使他们能够采用“全面”
研究方法。尽管有一些专门针对特定呼吸道微生物或
系统,这是唯一一场旨在将潜水员社区聚集在一起并鼓励年轻的会议
调查人员的参与使其与众不同。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Stacey L Schultz-C...的其他基金
Legacy of Obesity on Influenza and Coronavirus
肥胖对流感和冠状病毒的影响
- 批准号:1051607310516073
- 财政年份:2021
- 资助金额:$ 0.65万$ 0.65万
- 项目类别:
Legacy of Obesity on Influenza and Coronavirus
肥胖对流感和冠状病毒的影响
- 批准号:1035523910355239
- 财政年份:2021
- 资助金额:$ 0.65万$ 0.65万
- 项目类别:
Do they or don't they: astrovirus-induced diarrhea
是还是不是:星状病毒引起的腹泻
- 批准号:98041419804141
- 财政年份:2018
- 资助金额:$ 0.65万$ 0.65万
- 项目类别:
Beyond model development: murine astrovirus endogenous pathogens of laboratory mice
超越模型开发:实验小鼠的鼠星状病毒内源性病原体
- 批准号:91653299165329
- 财政年份:2016
- 资助金额:$ 0.65万$ 0.65万
- 项目类别:
6th Orthomyxovirus Research Conference
第六届正粘病毒研究会议
- 批准号:84001058400105
- 财政年份:2012
- 资助金额:$ 0.65万$ 0.65万
- 项目类别:
4th Orthomyxovirus Research Conference
第四届正粘病毒研究会议
- 批准号:72758507275850
- 财政年份:2007
- 资助金额:$ 0.65万$ 0.65万
- 项目类别:
Lethality of H5N1 Influenza Virus is Linked to TGF-beta
H5N1 流感病毒的致死率与 TGF-β 有关
- 批准号:68660406866040
- 财政年份:2005
- 资助金额:$ 0.65万$ 0.65万
- 项目类别:
Lethality of H5N1 Influenza Virus is Linked to TGF-beta
H5N1 流感病毒的致死率与 TGF-β 有关
- 批准号:71885377188537
- 财政年份:2005
- 资助金额:$ 0.65万$ 0.65万
- 项目类别:
相似海外基金
Pandemic preparedness for underserved persons in the US: Harnessing data from the RADx-UP consortium to assess public health tools for resource allocation
美国服务不足人群的流行病防范:利用 RADx-UP 联盟的数据评估用于资源分配的公共卫生工具
- 批准号:1088131910881319
- 财政年份:2023
- 资助金额:$ 0.65万$ 0.65万
- 项目类别:
Development of a Nematode-Derived Drug to Treat Asthma
开发线虫衍生药物来治疗哮喘
- 批准号:1060230910602309
- 财政年份:2023
- 资助金额:$ 0.65万$ 0.65万
- 项目类别:
Midcareer Investigator Award in Patient-Oriented Research in the Microbiome and Lung Disease
微生物组和肺部疾病以患者为导向的研究中的职业生涯中期研究员奖
- 批准号:1044666310446663
- 财政年份:2022
- 资助金额:$ 0.65万$ 0.65万
- 项目类别:
Midcareer Investigator Award in Patient-Oriented Research in the Microbiome and Lung Disease
微生物组和肺部疾病以患者为导向的研究中的职业生涯中期研究员奖
- 批准号:1061210510612105
- 财政年份:2022
- 资助金额:$ 0.65万$ 0.65万
- 项目类别:
Eliminating Monitor Overuse (EMO) Hybrid Effectiveness-Deimplementation Trial
消除显示器过度使用 (EMO) 混合有效性-取消实施试验
- 批准号:1068975410689754
- 财政年份:2021
- 资助金额:$ 0.65万$ 0.65万
- 项目类别: